ActivBiotics and DepoMed Announce Agreement to Develop New Product for the Treatment of Acute and Chronic Gastrointestinal Diseases.
Business Wire › October 15, 2002
Linked as:
Extract
ActivBiotics and DepoMed Announce Agreement to Develop New Product for the Treatment of Acute and Chronic Gastrointestinal Diseases.
Business Editors & Health/Medical Writers
CAMBRIDGE, Mass. & MENLO PARK, Calif.--(BUSINESS WIRE)--Oct. 15, 2002 ActivBiotics, Inc. and DepoMed, Inc. (AMEX:DMI) today announced a memorandum of understanding under which DepoMed will dev...See the full content of this document
Sponsored links
